MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647127597 A) filed by Gila Therapeutics, Inc. on October 26, 2026, for Compositions And Methods For Treating Metabolic Diseases With Topical-Lingual Receptor Agonists.
Inventor includes Vasicek, Thomas.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The invention provides compositions and methods for inducing satiety or treating a metabolic disorder. The compositions include pegsebrenatide, ecnoglutide, dapiglutide, tirzepatide, VK2735, efinopegdutide, cotadutide, mazdutide, or retatrutide, which can be administered topical-ling ually to provide treatment for obesity and metabolism related diso...